Sociétés des Produits Nestlé, a part of Nestlé Health Science, acquired the outstanding shares of California-based Aimmune for $2.6 billion in cash following years of increasing its financial position in the food allergy-focused company.
https://www.pharmalive.com/wp-content/uploads/2020/08/Nestlé-Snaps-Up-Outstanding-Shares-of-Aimmune-for-2.6-Billion-BioSpace-8-31-20.jpeg350625Andrew Humphreyshttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAndrew Humphreys2020-08-31 11:06:262020-08-31 23:07:56Nestlé Snaps Up Outstanding Shares of Aimmune for $2.6 Billion